{"result": "(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic condition characterized by high blood sugar levels due to insulin resistance or insufficient insulin production.)\n##\n(\"entity\"<|>FIBROSIS QUÍSTICA<|>EVENT<|>Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, often leading to diabetes as a comorbidity.)\n##\n(\"entity\"<|>LIPODISTROFIA CONGÉNITA GENERALIZADA<|>EVENT<|>Congenital generalized lipodystrophy is a rare hereditary disorder characterized by the near-total absence of adipose tissue from birth, leading to metabolic abnormalities.)\n##\n(\"entity\"<|>HÍPERTRIGLICERIDEMIA<|>EVENT<|>Hypertriglyceridemia is a condition characterized by elevated levels of triglycerides in the blood, often associated with diabetes and metabolic disorders.)\n##\n(\"entity\"<|>RESISTENCIA A LA INSULINA<|>EVENT<|>Insulin resistance is a condition where the body's cells become less responsive to insulin, leading to increased blood sugar levels and associated metabolic issues.)\n##\n(\"entity\"<|>ATEROSCLEROSIS<|>EVENT<|>Atherosclerosis is a disease in which plaque builds up inside the arteries, often exacerbated by diabetes and insulin resistance.)\n##\n(\"entity\"<|>CIRROSIS HEPÁTICA<|>EVENT<|>Liver cirrhosis is a late-stage liver disease characterized by scarring of the liver, which can be a consequence of diabetes and metabolic disorders.)\n##\n(\"relationship\"<|>DIABETES<|>FIBROSIS QUÍSTICA<|>Diabetes is a common comorbidity in patients with cystic fibrosis, affecting their metabolic health<|>8)\n##\n(\"relationship\"<|>LIPODISTROFIA CONGÉNITA GENERALIZADA<|>RESISTENCIA A LA INSULINA<|>Congenital generalized lipodystrophy is associated with insulin resistance due to the lack of adipose tissue<|>7)\n##\n(\"relationship\"<|>DIABETES<|>RESISTENCIA A LA INSULINA<|>Diabetes is characterized by insulin resistance, leading to elevated blood sugar levels<|>9)\n##\n(\"relationship\"<|>DIABETES<|>HÍPERTRIGLICERIDEMIA<|>Diabetes often leads to hypertriglyceridemia as a metabolic complication<|>8)\n##\n(\"relationship\"<|>RESISTENCIA A LA INSULINA<|>HÍPERTRIGLICERIDEMIA<|>Insulin resistance contributes to the development of hypertriglyceridemia<|>7)\n##\n(\"relationship\"<|>DIABETES<|>ATEROSCLEROSIS<|>Diabetes increases the risk of developing atherosclerosis due to metabolic changes<|>8)\n##\n(\"relationship\"<|>DIABETES<|>CIRROSIS HEPÁTICA<|>Diabetes can lead to liver cirrhosis as a result of metabolic complications<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: , y que se producen por mutaciones en el gen del receptor de la insulina, lo que se                                                        La diabetes relacionada con la fibrosis quística es la comorbilidad más frecuente en esta\n        traduce en una ausencia casi completa de su función.                                                                                               enfermedad, y afecta al 20% de los adolescentes y al 40-50% de los adultos.\n        La lipodistrofia congénita generalizada es un trastorno hereditario poco común, de herencia                                                        Referencias:\n        autosómica recesiva, caracterizado por la ausencia casi total de tejido adiposo desde el naci-                                                     • Boutzios G, Livadas S, Marinakis E, Opie N, Economou F, Diamanti-Kandarakis E. Endocrine and metabolic aspects of the Wolfram\n        miento. Se asocia a la aparición precoz de anomalías metabólicas como hipertrigliceridemia,                                                          syndrome. Endocrine. 2011;40(1):10-3.\n                                                                                                                                                           • Moran A, Pillay K, Becker D, Granados A, Hameed S, AceriniCL. ISPAD Clinical Practice Consensus Guidelines 2018: management of cystic\n        esteatosis hepática y resistencia a la insulina, que pueden acarrear consecuencias fatales                                                           fibrosis-related diabetes in children and adolescents.\n                                                                                                                                                             Pediatr Diabetes. 2018;19(Suppl.27):64-74.\n        debido al desarrollo de ateroesclerosis precoz, diabetes lipoatrófica y cirrosis hepática.                                                         • Niederau C, Strohmeyer G, Stremmel W. Epidemiology, clinical spectrum and prognosis of hemochromatosis. Adv Exp Med Biol. 1994;356:293.\n\n\n\n        Por tanto, estos tres síndromes se caracterizan por presentar una intensa resistencia a la\n        insulina.\n        Referencias:                                                                                                                             2.2 Fisiopatología\n        • Semple RK, Savage DB, Cochran EK, Gorden P, O’Rahilly S. Genetic syndromes of severe insulin resistance. Endocr Rev.\n          2011;32(4):498.\n                                                                                                                                                    21     En un paciente con DM1 recién diagnosticado y sin tratamiento con insulina,\n                                                                                                                                                           ¿qué alteraciones metabólicas no encontraremos?\n                                                                                                                                                           A. Aumento de la glucogenólisis.\n                                                                                                                                                           B. Disminución de la lipólisis.\n                                                                                                                                                           C. Aumento de la gluconeogénesis.\n                                                                                                                                                           D.  Disminución de la síntesis de proteínas.\n\n\n\n90                                                                                                                                                                                                                                                                                        91\n---\n                                                                                                                                                                                                                                             DIABETES                           2\n\n\n\n        COMENTARIO                                                                                                                                COMENTARIO\n        Entre las acciones biológicas de la insulina se encuentran: inhibición de la glucogenólisis                                               La resistencia a la insulina se asocia a un aumento de la gluconeogénesis hepática y de la gluco-\n        y la gluconeogénesis, reducción de la lipólisis y estimulación de la síntesis proteica. Por                                               genólisis hepática, lo que contribuye a la aparición de hiperglucemia, junto al aumento de la se-\n        tanto, el déficit absoluto o relativo de insulina provoca los siguientes efectos: aumento de                                              creción de glucagón. Además, la resistencia a la insulina determina una alteración del metabolis-\n        la glucogenólisis, aumento de la lipólisis, aumento de la gluconeogénesis, y aumento de la                                                mo lipídico con aumento de la producción de ácidos grasos libres. Es característico un aumento\n        proteólisis, con descenso de la síntesis proteica.                                                                                        del glucagón, que también influye en el incremento en la gluconeogénesis hepática, acoplado a\n        Estos efectos justifican las alteraciones características del déficit de insulina, con hiperglu-                                          la disminución de la síntesis de glucógeno y también al incremento de la glucogenólisis.\n        cemia, hiperlipidemia y aumento del catabolismo muscular.                                                                                 En la DM2 hay un incremento en la gluconeogénesis hepática acoplado a la disminución\n        Referencias:                                                                                                                              de la síntesis de glucógeno y también al incremento de la glucogenólisis. Estos fenómenos\n        •  Palmer BF, Clegg DJ. Electrolyte and Acid-Base Disturbances in Patients with Diabetes Mellitus. N Engl J Med. 2015;373(6):548-59.      se deben tanto a la reducción de la actividad insulínica como al incremento relativo en\n                                                                                                                                                  la concentración de glucagón plasmático.\n                                                                                                                                                  Referencias:\n    22  En sujetos con insulinorresistencia no se ha descrito:                                                                                    •  Butler PC, Rizza RA. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic\n                                                                                                                                                     glucose cycling in glucose-intolerant or NIDDM patients. Diabetes. 1991;40(1):73-81.\n        A. El aumento de masa de células\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}